Podcast - States Propose New Laws Affecting Healthcare Real Estate Investors and Owners
Hospice Insights Podcast - PPEO Playbook: The High-Stakes Game Hospices Can’t Afford to Lose
Podcast - Assessing the State of Healthcare Restructurings
Leaders in Law: Life Sciences and Technology Transactions with Jekkie Kim
Health-e Law Podcast, Episode 22 | J.P. Morgan Healthcare 2026 and Beyond: Regulation, Technology and the Future of Health Equity
Podcast — Spotlight on US State Healthcare Transaction Review Laws
Taking the Pulse: A Health Care and Life Sciences Video Podcast | Episode 268: Inside South Carolina’s Life Sciences Growth with James Chappell of SCbio
JONES DAY TALKS®: The CNPV Pilot Program: FDA's High-Speed Lane for Drug Approval
Hospice Insights Podcast - Endings and Beginnings: Reflections on Meg Pekarske’s 25+ Years as a Hospice Advocate
Health-e Law Podcast, Episode 21 | J.P. Morgan Healthcare 2026 and Beyond: Technology Adoption and Strategic Transformation Under Cost Pressure
Got an Audit Letter? Here’s What Every Health Care Provider Should Do
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 267: Leading Legal Strategy at a Growing Health System with Kelli Ferry of Novant Health
We get AI for work™: Preparing Real-World Healthcare Environments for an AI-Driven Future
Health-e Law Podcast, Episode 20 | J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A
Podcast - Minority Deals in Healthcare Private Equity: An Evolving Opportunity for GPs and Founders Counsel That Cares Podcast Series
Pay Transparency + the Power of Preventive Strategies: Episode 3 — Pivoting Toward Preparation in the Life Sciences
Pay Transparency + the Power of Preventive Strategies: Episode 2 — Healthcare Compliance Crossroads
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 266: Navigating Today’s Healthcare Landscape with Leighton Roper of Maynard Nexsen
Hospice Insights Podcast - Reimagining How We Navigate Change and Loss: A Conversation with Sonya Dolan and Bridget Sumser of Mettle Health
Podcast - The Fast-Growing Wound Care Industry
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
With the ever-increasing demands and expectations on documentation in clinical practice, more physicians are beginning to utilize Artificial Intelligence (AI) tools to more efficiently and effectively respond to such demands....more
During and after the COVID-19 Public Health Emergency, the Centers for Medicare & Medicaid Services (CMS) provided certain flexibilities and exercised enforcement discretion with respect to regulations affecting...more
Last week, the Washington and New York legislatures each passed two bills; chatbot bills advanced in Georgia, Hawaii, and Tennessee; the Hawaii House passed a pricing bill while Colorado and Massachusetts committees advanced...more
The U.S. Food and Drug Administration (FDA) released new guidance on February 23, 2026, which appears designed to embrace regulatory flexibility in order to allow accelerated access to therapies for patients with rare and...more
Genomic analysis has long been a focus of researchers. The advent of the Human Genome Project led to the successful mapping of the human genome and spurred further sequencing advancements. However, traditional tools often...more
In May 2023, Florida enacted a significant change to its health data laws. Senate Bill 264 amended the Florida Electronic Health Records Exchange Act restricting where certain patient data can be stored and accessed. Codified...more
After an unexpected, late-session veto, the effort to strengthen protections for consumer health information is back on the table in New York. Background and Legislative Context- The New York Health Information Privacy...more
If your company uses an AI-powered tool that remembers customer interactions, asks follow-up questions, and sustains personal conversations — even if you licensed it from a third-party vendor — Oregon's new chatbot safety law...more
Senate Aging Committee holds hearing on drug supply chain. Republicans and Democrats expressed interest in policy proposals to promote domestic drug production....more
The U.S. Food and Drug Administration (FDA)’s March 2026 update to its biosimilar Q&A guidance arrives at a critical inflection point for the biopharmaceutical sector, as the industry faces a looming “patent cliff” with more...more
In these uncertain times, it is more important than ever to review your fundamental estate planning documents to ensure that they protect you and your family and carry out your wishes....more
Wilson Sonsini’s 2025 Technology and Life Sciences IPO Report provides in-depth analysis on 40 initial public offerings (IPOs) and five direct listings completed by U.S.-based technology and life sciences companies in 2025...more
The Inflation Reduction Act (IRA) has reshaped how Medicare covers and reimburses prescription drugs. For the first time, the federal government established prices for ten drugs selected through the Medicare Drug Price...more
On 23 February 2026, the Italian Medicines Agency (AIFA) published the new Guidelines for defining and classifying non‑prescription medicines as OTC or SOP. This document describes the legal framework and sets detailed...more
The proverb “March comes in like a lion and goes out like a lamb” refers to typical March weather, which improves as the month goes on. Unfortunately, the same is not true for retirement plan and health plan compliance...more
Artificial Intelligence continues to move quickly into the clinical workflow. WVU Medicine recently announced that it is expanding its use of Abridge, an AI-powered transcription platform designed to generate clinical...more
Here are curated AG and federal regulatory news stories highlighting key areas in which state and federal regulators’ decisions are having an impact across the US: • Heavy Metal Headaches: AG Bonta Warns Baby Food Brands on...more
On March 3, 2026, FDA announced it had issued 30 warning letters to telehealth companies marketing compounded GLP‑1 products whose promotion of compounded GLP‑1s, in FDA’s view, implies equivalence to FDA-approved products...more
On March 11, the U.S. Department of Justice and U.S. Attorney’s Office announced that Aetna, a national health insurer, has agreed to pay $117,700,000 to settle alleged violations of the False Claims Act (FCA). The government...more
Health Information Exchange is essential to care delivery and innovation—but it is also increasingly a source of operational friction, contractual pressure, and privacy scrutiny as organizations reassess how health data is...more
Week nine of the 2026 Iowa Legislative Session featured a balance of floor debate, subcommittees, and committee meetings in both chambers. Because the second funnel deadline is this Friday, March 20, policy bills must move...more
The U.S. grocery and convenience retail sectors are facing a “perfect storm” of regulatory, economic, and behavioral shifts. The traditional Supplemental Nutrition Assistance Program (SNAP), which for decades operated under a...more
On February 26, 2026, the Trump Administration announced “new steps to crack down on fraud in Medicare and Medicaid to protect patients and taxpayers and improve affordability.” This includes (1) deferring $259.5 million of...more
The Minnesota Pollution Control Agency (MPCA) held a webinar on February 26, 2026, on its currently unavoidable use (CUU) rule concepts. Under Minnesota’s per- and polyfluoroalkyl substances (PFAS) statute, beginning January...more